Press Releases

Latest Releases

U.S. Senators Tina Smith, Todd Young Introduce Bipartisan Legislation to Help Farmers, Combat Climate Change

WASHINGTON, D.C. [7.11.23] – Today, U.S. Senators Tina Smith (D-MN) and Todd Young (R-IN) introduced bipartisan legislation that will help combat climate change and improve agricultural resilience and productivity. Experts estimate that American farmers could store up to 220 billion pounds of carbon annually across all US croplands. The Advancing Research on Agricultural Climate Impacts Act will bolster our understanding of soil carbon sequestration and help farmers enhance soil health, make their operations more resilient, and combat climate change. “Farmers in Minnesota don’t need to be told climate change is happening, they see it every year in the form of harsher droughts, more powerful storms and heatwaves. We need to be doing everything we can to combat this crisis and help farmers adapt to the changing climate,” said Senator Smith. “This bipartisan legislation would help farmers by funding new research to improve our understanding of soil carbon storage potential on agricultural land to inform best practices and help make farms more resilient. It’s a win for farmers and our climate. I’ll continue working hard to get it passed.” “Hoosier farmers and producers feed our communities, drive our economy, and play a critical role in our supply chains. This bipartisan legislation will equip and empower our agriculture sector to choose the best climate smart practices for their individual operations,” said Senator Young. “The bill would not only foster the adoption of beneficial soil practices, but also fortify the resilience and prosperity of our agricultural needs for generations to come.” The Advancing

U.S. Senator Tina Smith Reintroduces Legislation to Expand Access to Lifesaving HIV Prevention Drugs

WASHINGTON, D.C. [6.29.23] – This month, U.S. Senator Tina Smith (D-Minn.) and U.S. Representative Adam B. Schiff (D-Calif.) introduced legislation that will expand access to lifesaving HIV prevention medications. The PrEP Access and Coverage Act addresses the underutilization of HIV prevention drugs – known as PrEP (pre-exposure prophylaxis) and PEP (post-exposure prophylaxis) – by ensuring these medications and any associated costs are covered by health insurance. The measure also establishes community public health campaigns, and it expands access to the drugs for uninsured individuals and underserved communities. “Every person deserves access to affordable, high quality health care,” said Sen. Smith. “Too many people in Minnesota and across this country are unduly burdened by the high costs of HIV prevention drugs, and many others are going without this lifesaving preventative medication. This bill takes an important step towards ensuring that these highly effective medications are accessible and affordable for every patient who needs them.” “HIV prevention drugs shouldn’t be inaccessible and unaffordable,” said Rep. Schiff. “Senator Smith and I are reintroducing the PrEP Access and Coverage Act so that LGBTQ Americans – especially those from communities of color who experience disparities in health care – have access to the HIV medications and services they need.” “To end the HIV epidemic by 2030, we must expand our efforts to improve PrEP education and access,” said Torrian L. Baskerville, Director of HIV & Health Equity for the Human Rights Campaign Foundation. “It is especially critical to address decades-long inequities that disproportionately impact Black

U.S. Senator Tina Smith in Senate Speech: “Why I’m Sharing My Experience with Depression”

WASHINGTON, D.C. [05/15/19]—Today, U.S. Senator Tina Smith (D-Minn.) took to the Senate floor to share her own mental health story as part of her push to make access to mental health care for Minnesotans and Americans a top priority.   In her speech, Sen. Smith—a member of the Senate Health Committee—shared her own experiences with depression earlier in life, and highlighted the need to provide mental health support to people at every age across the nation in both rural and urban areas, no matter what zip code they live in. “That’s my story. Really, it’s the story of millions of

U.S. Senator Tina Smith Calls for Action to Protect Homebuyers from Predatory Lending

WASHINGTON, D.C. [05/13/19]—U.S. Senator Tina Smith (D-Minn.) is calling on the Consumer Financial Protection Bureau (CFPB)—to improve protections for Minnesotans and Americans purchasing manufactured homes, after hearing from multiple consumer advocates that unwitting home buyers are often steered toward higher-cost loans.      Sen. Smith—a member of the Senate Banking, Housing, and Urban Affairs—and eight of her Senate colleagues highlighted the lack of transparency manufactured homebuyers face when it comes to lending practices in a letter to CFPB Director Kathy Kraninger. The letter was led by Sen. Catherine Cortez Masto (D-Nev.).   “Typically, the majority of consumers who have not

Klobuchar Introduces Legislation to Provide Relief to Those Caring for Aging Relatives

WASHINGTON D.C. [05/10/2019] – U.S. Senator Amy Klobuchar (D-MN) reintroduced the Americans Giving Care to Elders (AGE) Act to provide financial relief to caregivers by creating a tax credit for the costs of caring for an aging relative. The AGE Act would allow families to qualify for a tax credit to help offset expenses—ranging from purchasing assistive technologies and devices, respite care, to making necessary home modifications—of up to $6,000 per year. Klobuchar first introduced the AGE Act in 2015. The bill is co-sponsored by Senators Mazie K. Hirono (D-HI), Tina Smith (D-MN), and Dianne Feinstein (D-CA). “We know that caregiving can be extremely expensive—especially when family

U.S. Senator Tina Smith Pushes for Prescription Drug Pricing Transparency

WASHINGTON, D.C. [05/09/19]—Today, U.S. Senator Tina Smith (D-Minn.) helped introduce bipartisan legislation to combat skyrocketing prescription drug prices. The Fair Accountability and Innovative Research (FAIR) Drug Pricing Act would require drug manufacturers to disclose and provide more information about planned drug price increases, including research and development costs. Increased transparency will help provide much-needed context for taxpayers, consumers, and policymakers about the costs and value of medications, and may also incentivize companies to reassess the long-standing practice of relentless drug price increases. The bill was led by Sens. Tammy Baldwin (D-Wisc.) and Mike Braun (R-Ind.), and Sen. Lisa Murkowski (R-Alaska) is a cosponsor. I’ve traveled around Minnesota to talk

en_USEnglish